07/11/2025
Turning purple for .
Our team is helping to raise awareness of the vital need for more into the of pancreatic cancer.
is the 10th most common cancer in the UK but the 5th most common cause of cancer death. This is because many patients are diagnosed late, when the is already at an advanced stage and treatment options are limited.
Our SAFE-D study is evaluating whether a new blood test can spot the signals of pancreatic cancer at an early stage when it is more treatable and will use blood samples from people with a recent diagnosis of type 2 – a known risk factor and potential sign or symptom of pancreatic cancer.
Find out more about the SAFE-D study here - https://safe-d.uk/
Pancreatic Cancer Action Network, Pancreatic Cancer UK, Cancer Research UK, Health Research Southampton, University of Southampton Medicine, University of Southampton